The production of gamma interferon in acute acquired and congenital toxoplasmosis was studied. Gamma interferon was produced at significant titers (P < 0.001) in the course of both congenital toxoplasmosis and acquired toxoplasmosis at an early stage of infection, when Toxoplasma gondii was multiplying. Its presence in fetal blood was correlated with the positive inoculation of fetal blood or amniotic fluid into mice (95%). The data suggest that the fetus is able to synthesize gamma interferon as early as week 21 of pregnancy. This test, easily and rapidly performed, could be included among those useful for diagnosing fetal toxoplasmic disease.
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More than 20 years have passed since it was first hypothesized that gamma interferon may play a major role in resistance to Toxoplasma gondii (9) . It was first suggested (1, 2) and then confirmed (27) that activated macrophages are the major effector of cell-mediated immunity against T. gondii. Gamma interferon was then identified as the lymphokine that activates human macrophages (17) , both in vivo and in vitro (15, 16, 28) . The important role of gamma interferon was studied first in mice, with murine recombinant gamma interferon (13, 15) , and then in cell cultures, with human recombinant gamma interferon (20) . One of the numerous mechanisms of action of gamma interferon against T. gondii is its parasitostatic effect through tryptophan starvation of cells (19) . The production of gamma interferon was demonstrated in infected mice (24) and in cultured human lymphocytes (11) with a monoclonal antibody.
It seemed of interest to investigate the production of gamma interferon directly in human blood from adults with acute acquired toxoplasmosis and then from fetuses suspected of having congenital toxoplasmosis.
A previous study (12) reported the presence of alpha interferon in fetal serum as a marker of congenital rubella. We verify that gamma interferon could be synthesized by the fetus and be of help in the same way for the antenatal diagnosis of toxoplasmosis.
Patient population. The acquired-toxoplasmosis study was done with 24 serum samples from 12 pregnant women with a seroconversion. A control group was formed of 23 serum samples from female blood donors and 20 serum samples from three women monitored once a month throughout pregnancy to check for their lack of immunity to T. gondii.
Gamma interferon production by the fetus during congenital toxoplasmosis was assayed by taking fetal blood samples between weeks 21 and 34 of gestation from 61 pregnant women who acquired toxoplasmosis during pregnancy. A 2-to 3-ml sample of fetal blood was obtained from the umbilical cord under ultrasound guidance. At the same time, to test for the presence of the parasite, we collected amniotic fluid for inoculation into mice and, in some cases, into cell cultures. The blood sample was first determined to be uncontaminated by maternal blood, by using the Kleihauer test, or by amniotic fluid, as previously described (8 Gamma interferon assay. All collected sera were tested for gamma interferon by a solid-phase radioimmunoassay (Centocor Corp.). Briefly, polystyrene beads coated with antihuman gamma interferon monoclonal antibodies were incubated with specimens and controls. Unbound material was removed, and beads were again incubated with anti-human gamma interferon monoclonal antibodies labeled with 1251. After washing, the bound radioactivity was determined by counting the beads in a well-type gamma counter. The gamma interferon concentrations in the specimens were determined with a standard curve. In this test, described by Chang et al. (4) , the monoclonal antibodies are specific for the epitopes of biological activity of human interferon (23) and can detect titers as low as 0.20 IU/ml.
To complete the study, an alpha interferon assay was performed as previously described (12) .
The results concerning patients with acute acquired toxoplasmosis are presented in Table 1 . Thirteen of 24 serum specimens (54%) were positive. Gamma interferon was detected in 9 of 12 patients with a seroconversion, in both studied serum samples in 4 patients and in only one of the two serum samples in 5 patients. Gamma interferon appeared early in the infection (before the IgM antibody increase in four patients) and disappeared quickly when the IgG titer rose (patients 2, 9, and 11). For patient 7, we tested one serum sample taken 1 month later; it had become negative. Gamma interferon titers ranged from 0.2 to 1.4 IU/ml, with a mean titer of 0.36 + 0.33 IU/ml.
In the control group only 1 serum sample of the 23 from female blood donors was positive, at a titer of 0.80 IU/ml; of the 20 serum samples from pregnant women, 2-from different donors-were positive at titers of 0.30 and 0.40 IU/ml. Overall, 3 (range, 0 to 0.80 IU/ml) and was significantly different from those obtained in the cases of acute toxoplasmosis (P < 0.001). Analysis of congenital toxoplasmosis was based on the combined results of four investigations: (i and ii) inoculation into mice of fetal blood (i) or amniotic fluid (ii), (iii) the presence of specific IgM in fetal blood, and (iv) the presence of gamma interferon in fetal serum (5) . It allowed us to determine that there were two groups ( For the 61 fetuses in groups 1 and 2, only three serum samples showed divergent results for inoculation into mice and gamma interferon; the total correlation was therefore 95%.
To complete the study, we checked for the possible presence of alpha interferon in 10 serum samples which were either positive or negative for gamma interferon. The results were negative in all cases.
Using a radioimmunoassay, we were able to investigate directly the production of human gamma interferon during acute acquired and congenital toxoplasmic disease. The presence of gamma interferon, at titers between 0.2 and 2 IU/ml, was thus detected for the first time. In the case of acute toxoplasmosis, gamma interferon was detected in 13 of 24 serum samples from 12 women with a seroconversion, at titers significantly higher than those in the control group (P < 0.001). Similarly, the difference in the proportion of positive sera between the control group (6.9%) and the acute-toxoplasmosis group (54%) was highly significant.
During the acute disease, the presence of gamma interferon was detected in four serum samples in which only IgM antibodies were increased and in four others in which no IgM or IgG was detected. We assume that these samples were Remington (2) and Nakamura et al. (16) . Its presence seems to be short-lived, since it generally disappears when IgG increases. The three serum samples positive for gamma interferon among the control group can be explained by the nonspecificity of gamma interferon induction. Although a good correlation exists between a toxoplasmic infection and the synthesis of gamma interferon (2, 10, 13, 19, 20, 24) , gamma interferon has been described in other parasitic infections, such as those caused by Trypanosoma cruzi and Leishmania, Chlamydia (16, 29) , Mycobacterium, Staphylococcus, Salmonella, and Shigella (14) spp.; malaria (22) ; herpes encephalitis (12) ; and those caused by any antigen that stimulates T lymphocytes (14, 17, 18) .
The baseline that we adopted for detecting gamma interferon may be considered too low; we took as positive a titer of 0.2 IU/ml. We judged this acceptable because of the high reliability of the radioimmunoassay (4). Indeed, this low titer is in agreement with those of Nathan et al. (17) and Black and Remington (2), who found for recombinant gamma interferon a biological activity of 0.1 IU/ml for alveolar macrophages.
The second part of this work was devoted to the study of 61 fetuses suspected of having toxoplasmic disease. A high correlation (95%) was observed between the presence of gamma interferon in the fetal sera and positive inoculation into mice, and there was a significant difference between the titers in infected and uninfected fetuses (P < 0.001). These results led to the following considerations. (i) Firstly, they confirm the presence of gamma interferon when T. gondii is circulating, in agreement with the results of Black and Remington (2). (ii) Secondly, they provide an important and rapid indication of fetal infection; the detection of gamma interferon is more reliable than is cell culturing (7) and is more sensitive than the determination of specific IgM antibodies in fetal blood (only 31.25% positive in group 2). In group 1, in the two positive cases, the synthesis of gamma interferon could be attributed to many other microbial or immune reasons (14) . However, it could also be due to congenital toxoplasmosis with no other specific or nonspecific marker. (iii) Thirdly, they confirm the ability ofthe fetus to synthesize gamma interferon. Indeed, in four studies (3, 25, 26, 28) , stimulated neonate lymphocytes were reported to have a low ability to produce gamma interferon. We have found gamma interferon in fetal blood at titers slightly higher (mean, 0.5 ± 0.46 IU/ml) than those present in acquired toxoplasmosis (mean, 0.36 + 0.33 IU/ml) in adults and as early as week 21 of gestation.
In conclusion, with 3 discordant serum samples of 61-1 in group 2 and 2 in group 1-this test is more sensitive than both the IgM antibody assay and cell culturing and results in a 95% correlation with inoculation of fetal blood or amniotic fluid into mice. It is easy to perform and provides results within 1 day. Gamma interferon is not specific for toxoplasmic infections, but during suspected congenital infections its detection becomes of interest when it is correlated with other specific or nonspecific signs. This test can become a welcome aid in the diagnosis of fetal toxoplasmosis. 
